The Medicare GLP-1 Bridge, explained
A temporary federal demonstration (the "Medicare GLP-1 Bridge") that, for the first time, gives some Medicare Part D members access to GLP-1s for weight loss — at roughly $50/mo after any deductible.
Verified June 2026 Source: Medicare Rights Center — GLP-1 weight-loss demonstration begins July 2026 ↗StartsJuly 1, 2026
Cost~$50/mo after deductible
WhoMedicare Part D members
Which drugs
Injectable Mounjaro, Ozempic, Wegovy, Zepbound, and the Wegovy pill (and Foundayo at ~$50/mo for eligible members).
Who qualifies
Medicare Part D members — either a stand-alone Part D plan in Original Medicare, or a Medicare Advantage plan that includes drug coverage.
The catch — read this
What to do
- Confirm you have Part D drug coverage (stand-alone Part D, or Medicare Advantage with drugs).
- Ask your plan whether it's participating in the GLP-1 Bridge demonstration and which drugs it covers.
- See your clinician to confirm you meet the clinical criteria and get the prescription routed correctly.
- If your plan says no or you're unsure, check the official CMS Medicare GLP-1 Bridge page.